Lineage Cell Therapeutics LCTX
NYSE LCTX
$1.00 +0.02 (+2.04%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Purchase of Investments (2022 - 2026)

Updated

Analysis

Lineage Cell Therapeutics (LCTX) Purchase of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Lineage Cell Therapeutics 252.91 Mn 51.31 Mn - 10.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.43 Mn
Mar 31, 2026 8.24 Mn
Dec 31, 2025 14.94 Mn
Jun 30, 2024 8.76 Mn
Sep 30, 2023 3.77 Mn
Jun 30, 2023 4.92 Mn
Mar 31, 2023 7.72 Mn
Dec 31, 2022 12.78 Mn
API Access

Lineage Cell Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEY